LANOXIN®
(digoxin) Tablets, USP
125 mcg (0.125 mg) Scored I.D. Imprint Y3B (yellow)
250 mcg (0.25 mg) Scored I.D. Imprint X3A (white)
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
LANOXIN®
(digoxin)
Injection
500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL)
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
LANOXIN®
(digoxin)
Injection Pediatric
100 mcg (0.1 mg) in 1 mL
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS